5-aminolevulinic acid fluorescence in high grade glioma surgery: Surgical outcome, intraoperative findings, and fluorescence patterns

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Puppa, Alessandro Della ^a   Ciccarino, Pietro ^a   Lombardi, Giuseppe ^b   Rolma, Giuseppe ^a   Cecchin, Diego ^c   Rossetto, Marta ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; FEMALE; FLUORESCENCE; GLIOMA; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; NEURONAVIGATION; OLIGODENDROGLIOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; TUMOR LOCALIZATION; TUMOR VOLUME; BRAIN NEOPLASMS; CLINICAL TRIAL; MIDDLE AGED; MORTALITY; PATHOLOGY; PEROPERATIVE CARE; PROCEDURES;

AMINOLEVULINIC ACID; BRAIN NEOPLASMS; FEMALE; FLUORESCENCE; GLIOMA; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; NEOPLASM GRADING; PHOTOSENSITIZING AGENTS; RETROSPECTIVE STUDIES;

EID: 84900332387     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/232561     Document Type: Article

References (25)

1. Sanai N., Berger M. S., Glioma extent of resection and its impact on patient outcome. Neurosurgery 2008 62 4 753 764 2-s2.0-48949107730 10.1227/01.neu.0000318159.21731.cf
2. Hardesty D. A., Sanai N., The value of glioma extent of resection in the modern neurosurgical era. Frontiers in Neurology 2012 3, article 140
3. McGirt M. J., Mukherjee D., Chaichana K. L., Than K. D., Weingart J. D., Quinones-Hinojosa A., Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 2009 65 3 463 469 2-s2.0-69549110726 10.1227/01.NEU.0000349763. 42238.E9
4. Lacroix M., Abi-Said D., Fourney D. R., Gokaslan Z. L., Shi W., DeMonte F., Lang F. F., McCutcheon I. E., Hassenbusch S. J., Holland E., Hess K., Michael C., Miller D., Sawaya R., A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. Journal of Neurosurgery 2001 95 2 190 198 2-s2.0-0034871451 (Pubitemid 32799739)
5. Sanai N., Polley M., McDermott M. W., Parsa A. T., Berger M. S., An extent of resection threshold for newly diagnosed glioblastomas: clinical article. Journal of Neurosurgery 2011 115 1 3 8 2-s2.0-79960001570 10.3171/2011.2.JNS10998
6. Keles G. E., Lamborn K. R., Chang S. M., Prados M. D., Berger M. S., Volume of residual disease as a predictor of outcome in adult patients with recurrent supratentorial glioblastomas multiforme who are undergoing chemotherapy. Journal of Neurosurgery 2004 100 1 41 46 2-s2.0-0347624010 (Pubitemid 38017813)
7. Chaichana K. L., Jusue-Torres I., Navarro-Ramirez R., Raza S. M., Pascual-Gallego M., Ibrahim A., Hernandez-Hermann M., Gomez L., Ye X., Weingart J. D., Olivi A., Blakeley J., Gallia G. L., Lim M., Brem H., Quinones-Hinojosa A., Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. Neuro-Oncology 2014 1 113 122
8. Idoate M. A., Díez Valle R., Echeveste J., Tejada S., Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence. Neuropathology 2011 31 6 575 582 2-s2.0-81955160890 10.1111/j.1440-1789.2011.01202.x
9. Stummer W., Pichlmeier U., Meinel T., Wiestler O. D., Zanella F., Reulen H., Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. The Lancet Oncology 2006 7 5 392 401 2-s2.0-33645986455 10.1016/S1470-2045(06)70665- 9
10. Stummer W., Reulen H., Meinel T., Pichlmeier U., Schumacher W., Tonn J., Rohde V., Oppel F., Turowski B., Woiciechowsky C., Franz K., Pietsch T., Oppel F., Brune A., Lanksch W., Woiciechowsky C., Brock M., Vesper J., Tonn J.-C., Goetz C., Gilsbach J. M., Mayfrank L., Oertel M. F., Seifert V., Franz K., Bink A. J. W., Schackert G., Pinzer T., Hassler W., Bani A., Meisel H.-J., Kern B. C., Mehdorn H. M., Nabavi A., Brawanski A., Ullrich O. W., Böker D. K., Winking M., Weber F., Langenbach U., Westphal M., Kähler U., Arnold H., Knopp U., Grumme T., Stretz T., Stolke D., Wiedemayer H., Turowski B., Pietsch T., Wiestler O. D., Reulen H.-J., Stummer W., Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery 2008 62 3 564 576 2-s2.0-42449117269
11. Feigl G. C., Ritz R., Moraes M., Klein J., Ramina K., Gharabaghi A., Krischek B., Danz S., Bornemann A., Liebsch M., Tatagiba M. S., Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. Journal of Neurosurgery 2010 113 2 352 357 2-s2.0-77955608608 10.3171/2009.10.JNS09447
12. Díez Valle R., Tejada Solis S., Idoate Gastearena M. A., García de Eulate R., Domínguez Echávarri P., Aristu Mendiroz J., Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. Journal of Neuro-Oncology 2011 102 1 105 113 2-s2.0-79952193058 10.1007/s11060-010-0296- 4
13. Schucht P., Beck J., Abu-Isa J., Andereggen L., Murek M., Seidel K., Stieglitz L., Raabe A., Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-ALA intraoperative fluorescence imaging and brain mapping. Neurosurgery 2012 71 5 927 935
14. Sawaya R., Hammoud M., Schoppa D., Hess K. R., Wu S. Z., Shi W., Wildrick D. M., Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 1998 42 5 1044 1055 2-s2.0-0031968492
15. Stummer W., Novotny A., Stepp H., Goetz C., Bise K., Reulen H. J., Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. Journal of Neurosurgery 2000 93 6 1003 1013 2-s2.0-0034433453 (Pubitemid 32800611)
16. della Puppa A., de Pellegrin S., d'Avella E., Gioffrè G., Rossetto M., Gerardi A., Lombardi G., Manara R., Munari M., Saladini M., Scienza R., 5-aminolevulinic acid (5-ALA) fluorescence guided surgery of high-grade gliomas in eloquent areas assisted by functional mapping. Our experience and review of the literature. Acta Neurochirurgica 2013 155 6 965 972
17. Butowski N., Lamborn K. R., Berger M. S., Prados M. D., Chang S. M., Historical controls for phase II surgically based trials requiring gross total resection of glioblastoma multiforme. Journal of Neuro-Oncology 2007 85 1 87 94 2-s2.0-34548769407 10.1007/s11060-007-9388-1 (Pubitemid 47422661)
18. Vogelbaum M. A., Jost S., Aghi M. K., Heimberger A. B., Sampson J. H., Wen P. Y., MacDonald D. R., van den Bent M. J., Chang S. M., Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) working group. Neurosurgery 2012 70 1 234 243 2-s2.0-84856114191 10.1227/NEU.0b013e318223f5a7
19. Rampazzo E., della Puppa A., Frasson C., Battilana G., Bianco S., Scienza R., Basso G., Persano L., Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery. Journal of Neuro-Oncology 2014 116 3 505 513
20. Louis D. N., Ohgaki H., Wiestler O. D., Cavenee W. K., Burger P. C., Jouvet A., Scheithauer B. W., Kleihues P., The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 2007 114 2 97 109 2-s2.0-34547122001 10.1007/s00401-007-0243-4 (Pubitemid 47103521)
21. Senft C., Forster M., Bink A., Mittelbronn M., Franz K., Seifert V., Szelényi A., Optimizing the extent of resection in eloquently located gliomas by combining intraoperative MRI guidance with intraoperative neurophysiological monitoring. Journal of Neuro-Oncology 2012 109 1 81 90 2-s2.0-84859628576 10.1007/s11060-012-0864-x
22. Nabavi A., Black P. M., Gering D. T., Westin C., Mehta V., Pergolizzi R. S. Jr., Ferrant M., Warfield S. K., Hata N., Schwartz R. B., Wells W. M. III, Kikinis R., Jolesz F. A., Serial intraoperative magnetic resonance imaging of brain shift. Neurosurgery 2001 48 4 787 797 2-s2.0-0035061899
23. Schucht P., Knittel S., Slotboom J., Seidel K., Murek M., Jilch A., Raabe A., Beck J., 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma. Acta Neurochirurgica 2014 156 2 305 312
24. Persano L., Rampazzo E., della Puppa A., Pistollato F., Basso G., The three-layer concentric model of glioblastoma: cancer stem cells, microenvironmental regulation, and therapeutic implications. TheScientificWorldJournal 2011 11 1829 1841 2-s2.0-81455142965 10.1100/2011/736480
25. Widhalm G., Wolfsberger S., Minchev G., Woehrer A., Krssak M., Czech T., Prayer D., Asenbaum S., Hainfellner J. A., Knosp E., 5-aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhancement. Cancer 2010 116 6 1545 1552 2-s2.0-77949404789 10.1002/cncr.24903